Search Results 51-60 of 16767 for alt

  1. Intravenous Ketamine For Treatment-Resistant Depression - Mayo Clinic

    * Hepatic insufficiency (2.5 X ULN for AST or ALT) within 1 year of consent, past liver transplant recipient, and/or clinical diagnosis of cirrhosis of the ...

  2. Thrombocytosis - Symptoms and causes - Mayo Clinic

    This condition occurs when your body produces too many platelets, the cells that help blood clot. Thrombocytosis can cause clotting or bleeding problems.

  3. Mayo Clinic researchers identify link between gut bacteria and pre-clinical autoimmunity and aging in rheumatoid arthritis

    They published their findings in a recent study in Science Advances. This image has an empty alt attribute; its file name is MSS_0001342127.jpg- Veena ...

  4. Biliary atresia - Symptoms and causes - Mayo Clinic

    Related. Associated Procedures. Alanine aminotransferase (ALT) blood test ...

  5. Hepatitis B - Diagnosis and treatment - Mayo Clinic

    More Information. Hepatitis B and Hepatitis C: What's the difference? Alanine aminotransferase (ALT) blood test · Alkaline phosphatase (ALP) blood test ...

  6. Effects Of NNC0194-0499, Cagrilintide, And Semaglutide Alone Or Combined With Semaglutide On Liver Damage And Alcohol Use In Alcohol-Related Liver Disease - Mayo Clinic

    ALT > 5x ULN at V1 or AST > 5x ULN at V1. · Total bilirubin > 1.5 mg/dL at Vl. · Alkaline phosphatase levels > 2 x ULN at Vl. · INR of prothrombin time ≥ 1.35 at ...

  7. Hemochromatosis - Symptoms and causes - Mayo Clinic

    Hemochromatosis, also called primary or hereditary hemochromatosis, is the most common iron overload disease. It is a genetic condition that triggers the ...

  8. A Study To Evaluate ALN-6400 In Healthy Volunteers And Patients With Hereditary Hemorrhagic Telangiectasia (HHT) - Mayo Clinic

    * Has ALT or AST \>2×ULN * Has total bilirubin \>1.5×ULN * Has eGFR of \<30 mL/min/1.73m\^2 at screening. Parts A and B: * Is not willing to comply with the ...

  9. A Study to Evaluate Hepatotoxicity Risk Associated with TURALIO™ (pexidartinib) Treatment - Mayo Clinic

    AST or ALT > 3 × ULN with concurrent total bilirubin > 2 × ULN;; Isolated total bilirubin > 2 × ULN (excluding patients with Gilbert's syndrome);; Isolated ...

  10. Publications - Mithri Junna, M.D. - Mayo Clinic

    Chang JL, Goldberg AN, Alt JA, Mohammed A, Ashbrook L, Auckley D, Ayappa I, Bakhtiar H, Barrera JE, Bartley BL, Billings ME, Boon MS, Bosschieter P ...